- May set up a wholly owned subsidiary of regenerative medicine
- Beginning in June the immune cells store technology
- In June set up a wholly owned subsidiary of medical materials
- July collaboration with Peking University to set up a "Northern Hao Institute for stem cell and regenerative medicine"
- September professional incubator set up the life and health industry
- November "human regeneration cartilage tissue engineering technology" by medical device manufacturing management code certification
- January appeared in the "Forbes top 200 potential enterprises in China", 57th place
- July landed successfully listed on the growth enterprise market of the stock exchange, Shenzhen, China
- In December, "b-hard-brain (Ridge) membrane patch" for CFDA registration form
- In January by the national development and Reform Commission approved the construction of "regenerative bio-high-tech industrialization demonstration project"
- Set up branch offices in Hong Kong in February "
- In July, the "germ-free bio-band membrane" for CFDA registration form
- In December, "the team focused on overseas Chinese entrepreneurship" title
- In June by the national development and Reform Commission awarding the construction of "National Engineering Laboratory for regenerative medical Implantable devices"
- Official launch in November a new English name Zhishang BiotechCo.,Ltd
- In January, "small-caliber prosthetic vascular" national 863 project
- In December the "thoracic and general surgery repair film" registered with the CFDA
- May moved to Guangzhou international business incubator
- In June the first product "biological hard-brain (Ridge) membrane patch" was awarded the CFDA registration form